Markets:

Overview

News

Currencies

International

Treasuries

CorMedix Inc. - Common Stock (NQ:CRMD)

8.580 +0.040 (+0.47%)

Streaming Delayed Price Updated: 2:06 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CorMedix Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Cormedix's Return On Capital Employed Insights ↗

March 30, 2022

According to data from Benzinga Pro, during Q4, Cormedix's (NASDAQ:CRMD) reported sales totaled $56.40 thousand. Despite a 9.08% increase in earnings, the company posted a loss of $7.79 million.

Via Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 28, 2022

Gainers NexImmune (NASDAQ:NEXI) stock moved upwards by 8.3% to $3.51 during Monday's after-market session. This security traded at a volume of 109.1K shares come close, making up 76.6% of its average...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 28, 2022

Gainers IntriCon (NASDAQ:IIN) shares increased by 37.4% to $23.93 during Monday's regular session. The current volume of 1.0 million shares is 3684.0% of IntriCon'...

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

CorMedix Refiles DefenCath US Application For Catheter-Related Bloodstream Infections ↗

February 28, 2022

CorMedix Inc (NASDAQ: CRMD) has resubmitted the New Drug Application (NDA) for DefenCath to address the Complete Response Letter (CRL) issued by the FDA. In...

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 12, 2021

Good morning! We're kicking off the final day of the trading week with an overview of the biggest pre-market stock movers for Monday!

Via InvestorPlace

50 Stocks Moving In Friday's Mid-Day Session ↗

March 11, 2022

Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares rose 63.5% to $1.13....

Via Benzinga

CorMedix Inc Common Stock (CRMD) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

CRMD earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Cormedix's Return On Capital Employed Insights ↗

November 09, 2021

According to Benzinga Pro data, during Q2, Cormedix (AMEX:CRMD) posted sales of $8.19 thousand. Earnings were up 18.42%, but Cormedix still reported an overall loss of $5.88...

Via Benzinga

67 Biggest Movers From Yesterday ↗

March 01, 2022

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 02, 2021

Gainers Bone Biologics (NASDAQ:BBLG) shares rose 33.57% to $7.32 during Tuesday's pre-market session. The company's market cap stands at $224.5 million. Artelo...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

24 Stocks Moving in Tuesday's Pre-Market Session ↗

November 02, 2021

Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) rose 119% to $3.43 in pre-market trading after declining 3% on Monday. The company, last month, swung to a loss...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 01, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 01, 2021

Welcome back, investor! We're starting off the trading week with a breakdown of the biggest pre-market stock movers for Monday!

Via InvestorPlace

Cormedix's Return On Capital Employed Overview ↗

September 30, 2021

According to data from Benzinga Pro, during Q2, Cormedix's (AMEX:CRMD) reported sales totaled $8.19 thousand. Despite a 18.42% increase in earnings, the company posted a loss of $...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher ↗

September 07, 2021

Toward the end of trading Tuesday, the Dow traded down 0.65% to 35,138.64 while the NASDAQ rose 0.13% to 15,383.18. The S&P also fell, dropping 0.27% to 4,522.99. The U.S. has...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Dow Drops Triple Digits as Economic Sentiment Sours ↗

September 07, 2021

The Dow Jones Industrial Index is kicking off the holiday-shortened week on a sour note, down roughly 290 points this afternoon.

Via Talk Markets

Topics Stocks

72 Biggest Movers From Yesterday ↗

September 08, 2021

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 07, 2021

Gainers Surrozen (NASDAQ:SRZN) stock rose 33.14% to $9.64 during Tuesday's regular session. The company's market cap stands at $351.2 million. ZIOPHARM Oncology (...

Via Benzinga

Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump ↗

September 07, 2021

Midway through trading Tuesday, the Dow traded down 0.76% to 35,098.84 while the NASDAQ rose 0.09% to 15,376.87. The S&P also fell, dropping 0.33% to 4,520.38. The U.S. has...

Via Benzinga

Topics Stocks

45 Stocks Moving In Tuesday's Mid-Day Session ↗

September 07, 2021

Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...

Via Benzinga

Why CorMedix Stock Is Getting Crushed Today ↗

September 07, 2021

The company announced a delay with resubmitting for FDA approval of its DefenCath antibacterial and antifungal solution.

Via The Motley Fool

Mid-Morning Market Update: Markets Open Lower; Avantor To Acquire Masterflex ↗

September 07, 2021

Following the market opening Tuesday, the Dow traded down 0.59% to 35,159.50 while the NASDAQ fell 0.05% to 15,355.16. The S&P also fell, dropping 0.35% to 4,519.52. The U.S....

Via Benzinga

Topics Stocks

Why Is CorMedix Stock Dropping On Tuesday? ↗

September 07, 2021

CorMedix Inc (NASDAQ: CRMD) stock is plunging after updating its resubmission timeline for the DefenCath marketing application. CorMedix has encountered delays at...

Via Benzinga

78 Biggest Movers From Friday ↗

August 16, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...

Via Benzinga

53 Stocks Moving In Friday's Mid-Day Session ↗

August 13, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said it continues to experience demand...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.